Novartis to buy BMS OTC brands for $660 million

July 15 2005

Novartis is buying the U.S. and Canadian OTC business of Bristol-Myers Squibb for $660 million, giving the Swiss firm entry ...

Your Name: *

Your Email Address: *

Recipient(s) Email Address: *

(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)

Subject:*

Your message:

Send Me A Copy

The e-mail address(es) that you supply to use this service will only be used to send the requested article.